BORA PHARMACEUTICALS LTD
Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services fo… Read more
BORA PHARMACEUTICALS LTD (6472) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.036x
Based on the latest financial reports, BORA PHARMACEUTICALS LTD (6472) has a cash flow conversion efficiency ratio of 0.036x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$569.50 Million) by net assets (NT$15.69 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BORA PHARMACEUTICALS LTD - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how BORA PHARMACEUTICALS LTD's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BORA PHARMACEUTICALS LTD Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BORA PHARMACEUTICALS LTD ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brigade Enterprises Limited
NSE:BRIGADE
|
-0.026x |
|
MFA Financial Inc
NYSE:MFA
|
0.008x |
|
IDT Corporation
NYSE:IDT
|
-0.029x |
|
Xinxiang Richful Lube Additive Co. Ltd
SHE:300910
|
0.093x |
|
Yantai Tayho Advanced Materials Co Ltd
SHE:002254
|
0.045x |
|
Jihua Group Corp Ltd
SHG:601718
|
0.043x |
|
CTEEP - Companhia de Transmissão de Energia Elétrica Paulista S.A
SA:TRPL3
|
-0.006x |
|
Ship Healthcare Holdings Inc
PINK:SHHPF
|
N/A |
Annual Cash Flow Conversion Efficiency for BORA PHARMACEUTICALS LTD (2019–2024)
The table below shows the annual cash flow conversion efficiency of BORA PHARMACEUTICALS LTD from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | NT$15.01 Billion | NT$980.81 Million | 0.065x | -83.34% |
| 2023-09-30 | NT$11.77 Billion | NT$4.61 Billion | 0.392x | +0.28% |
| 2022-09-30 | NT$5.14 Billion | NT$2.01 Billion | 0.391x | -0.32% |
| 2021-09-30 | NT$3.15 Billion | NT$1.24 Billion | 0.392x | +443.81% |
| 2020-09-30 | NT$2.46 Billion | NT$177.79 Million | 0.072x | -48.53% |
| 2019-09-30 | NT$1.65 Billion | NT$231.77 Million | 0.140x | -- |